share

(6R,7R)-7α-Amino-8-Oxo-3-(1,2,3-Thiadiazol-5-Ylthiomethyl)-5-Thia-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid CAS NO 95529-25-2


Unit Price:

CAS No.:95529-25-2

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

(6R,7R)-7α-Amino-8-Oxo-3-(1,2,3-Thiadiazol-5-Ylthiomethyl)-5-Thia-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid is a key advanced pharmaceutical intermediate, specifically a cephalosporin nucleus derivative. This compound is critical for the synthesis of modern, broad-spectrum cephalosporin antibiotics, offering a foundation for developing drugs with enhanced efficacy. It is primarily required by pharmaceutical R&D laboratories and API manufacturers focused on next-generation anti-infective therapies.

Application

  • Pharmaceutical Intermediate: Serves as a crucial building block in the synthesis of advanced third and fourth-generation cephalosporin antibiotics.
  • Active Pharmaceutical Ingredient (API) Development: Used in research and process development for novel antibacterial agents targeting resistant pathogens.
  • Chemical Synthesis Research: Employed in academic and industrial laboratories for studying structure-activity relationships in β-lactam chemistry.
  • Process Chemistry: Integral in scaling up and optimizing manufacturing routes for final antibiotic drug substances.

Basic Information

Product Name (6R,7R)-7α-Amino-8-Oxo-3-(1,2,3-Thiadiazol-5-Ylthiomethyl)-5-Thia-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid
CAS No. 95529-25-2
Molecular Formula C11H11N5O3S3
Molecular Weight 373.43 g/mol
Synonyms 7-ACA Thiadiazole Derivative; 7-Aminocephalosporanic Acid Thiadiazolylthiomethyl Derivative; 7β-Amino-3-[(1,2,3-thiadiazol-5-ylthio)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cephalosporin C Nucleus Analog; (6R,7R)-7-Amino-3-((1,2,3-thiadiazol-5-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
EINECS Contact for details

Quality Control

Our production of this high-value intermediate adheres to strict quality management systems, ensuring batch-to-batch consistency for critical pharmaceutical synthesis. Quality is verified through comprehensive analytical methods including HPLC, NMR, and MS. A Certificate of Analysis (COA) detailing purity, identity, and impurity profiles is provided with each shipment to support your regulatory and R&D requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). The product is moisture-sensitive; keep the container tightly sealed in a dry environment. For long-term storage, consider conditions under an inert atmosphere.

Specification

Item Specification
Appearance White to off-white powder
Identification (HPLC) Conforms to reference standard
Identification (IR) Conforms to structure
Assay (HPLC) ≥ 98.0%
Water Content (KF) ≤ 1.0%
Residue on Ignition ≤ 0.5%
Related Substances (HPLC) Total impurities ≤ 2.0% Any single impurity ≤ 1.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.